Description |
Stattic is a potent inhibitor of STAT3 activation and dimerization.
|
Target |
STAT3
|
In Vitro |
Stattic inhibits STAT3 phosphorylation (Y705) in ALDH+ and D44+/CD24+ subpopulations of Panc-1 and HPAC pancreatic cancer cell lines at a higher concenration (20 μM). Stattic selectively inhibits P-STAT3 as demonstrated by the lack of inhibition of P-ERK1/2 in both ALDH+ and CD44+/CD24+ subpopulations of Panc-1 and HPAC. Stattic inhibita STAT3 downstream targets in ALDH+ and CD44+/CD24+ subpopulations of pancreatic cancer cells[1]. Stattic reduces the LPS-induced expression of ICAM-1 and VCAM-1, and STAT3 phosphorylation[2].
|
Cell Assay |
Pancreatic cancer stem-like cells (3,000/well in 96-well plates) are incubated with desired concentrations of compounds in triplicate at 37˚C for 72 h. MTT viability assays are done and the absorbance is read at 595 nm.
|
Density | 1.6±0.1 g/cm3 |
Boiling Point | 461.1±45.0 °C at 760 mmHg |
Flash Point | 232.6±28.7 °C |
Exact Mass | 210.993927 |
PSA | 88.34000 |
LogP | 1.31 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Storage condition | Store at +4°C |